Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
J Environ Biol ; 2019 Jul; 40(4): 661-667
Article | IMSEAR | ID: sea-214605

ABSTRACT

Aim: The objective of the study was to assess the effect of dietary incorporation of different feed attractants viz. tubifex, earthworm and fish meal on growth and survival of O. bimaculatus (pabda fish) fry. Methodology: Fifty numbers of fifteen days weaned fry (0.105±0.008g; 2.14±0.14cm) were stocked into each aerated aquariums (30.0 x 15.0 x 15.0 cm) following a completely randomized design (CRD) consisting of four treatments including the control with three replicates each. Four iso-nitrogenous purified diets were prepared including three treatment diets with attractants (5%) by replacing an appropriate amount of casein and cellulose and fed to the fishes twice daily. Results: Results from the study showed that growth of fry as measured by final weight, weight gain, mean daily weight gain and specific growth rate of fries were significantly (p<0.05) higher in tubifex supplemented group and lower in control group. Survival was significantly higher in tubifex supplemented group (42.66±1.3%) and lower in control group. Moreover, other yield parameters such as total biomass, condition factor and performance index also followed the same trend as survival. Further, higher protease activity was found in control group (2.233±0.038 units mg protein-1 min-1) followed by earthworm (0.354±0.031 mg protein-1 min-1) supplemented group (p<0.05). The lipase and amylase activity were higher (p<0.05) in tubifex and control groups, respectively. Interpretation: It could be concluded that the dietary supplementation of tubifex at 5% inclusion level could be a promising aquaculture feeding strategy for pabda fish due to its rich nutrient content, increased feeding stimulation and more palatability.

2.
Indian Pediatr ; 2009 Sept; 46(9): 791-793
Article in English | IMSEAR | ID: sea-144177

ABSTRACT

Lead levels were measured by atomic absorption spectrophotometry in umbilical cord blood samples of 205 consecutively born neonates and venous blood in 62 of the mothers. The mean (± SD) cord blood lead level was 4.7 ± 12.1 µg/dL. In the sub sample of 62 mother-baby pairs, the mean (± SD) cord blood lead levels were 1.6 ± 2.5 µg/dL and 2.0 ± 2.1 µg/dL, respectively. According to CDC risk categories, 92% babies were in Class I of which 87% had lead levels below 5 µg/dL. The mean (± SD) birthweight in <5 µg/dL category was 2640 ± 445 grams as compared to 2617 ± 408 grams in >5 µg/dL category. The mean (± SD) gestational ages were 39.1 ± 2.0 weeks and 38.1±2.0 weeks, respectively in the two groups (P=0.014). On multivariate linear analysis, lower gestational age significantly correlated with higher cord blood lead level.


Subject(s)
Cross-Sectional Studies , Female , Fetal Blood/chemistry , Humans , India , Infant, Newborn , Lead/blood , Lead Poisoning, Nervous System, Childhood/blood , Male , Spectrophotometry, Atomic , Umbilical Cord/blood
3.
Indian J Hum Genet ; 2007 May; 13(2): 65-68
Article in English | IMSEAR | ID: sea-138828

ABSTRACT

BACKGROUND: Paraoxonase (PON1) can hydrolyze organophosphate pesticides (OP) and has a key role in the susceptibility of human in OP toxicity. The human-enzyme shows polymorphism and variations in the distribution profile of its phenotypes among different ethnic groups have been observed. AIMS: To see the distribution pattern of total PON1 activity in 45 healthy attendants of poisoning cases; 121 healthy unrelated farm-labours and 59 normal subjects of trauma. MATERIALS AND METHODS: The PON1 activities from serum/plasma samples of these healthy normal individuals were estimated with/without addition of 1M NaCl in order to determine salt-stimulated and basal activity. The PON 1 phenotypes were determined on the basis of percent activation of enzyme activity. RESULTS: Tri-modal distribution of basal PON1 activity was observed among all these individuals. 52.0% of the individuals belonged to Phenotype A, 46.6% to phenotype AB while 1.4% to Phenotype B with gene frequency of allele-A and allele-B being 0.753 and 0.247 respectively in excellent agreement with Hardy-Weinberg equilibrium. CONCLUSION: Maximum number of individuals belonged to phenotype-A (low PON1 activity) showing potential vulnerability towards Op-poisoning.

4.
Indian Pediatr ; 2001 Dec; 38(12): 1427
Article in English | IMSEAR | ID: sea-9395
5.
Indian Pediatr ; 2001 Nov; 38(11): 1316
Article in English | IMSEAR | ID: sea-14279
7.
Indian Pediatr ; 2001 Jan; 38(1): 98
Article in English | IMSEAR | ID: sea-13536
8.
Indian Pediatr ; 2000 Dec; 37(12): 1386
Article in English | IMSEAR | ID: sea-13453
9.
Indian J Pediatr ; 2000 Aug; 67(8): 563-6
Article in English | IMSEAR | ID: sea-80479

ABSTRACT

Rheumatic chorea is the sole neurologic manifestation of rheumatic fever. It is a debilitating illness lasting for weeks to months. Drugs like diazepam, haloperidol, chlorpromazine take four to six weeks for functional improvement and can cause serious side effects. The authors investigated the role of Vitamin E in reducing rheumatic chorea. A case series of patients of rheumatic chorea were administered Vitamin E in the dose 50 IU daily for fifteen days. The various clinical signs of rheumatic chorea were scored with MAIMS score (Modified Abnormal Involuntary Movement Scale score) which is used for tardive dyskinesia. No other drug for abnormal movements was used. In all the 4 patients who received vitamin E, there was remarkable change by 7th day and almost complete functional improvement by 14th day. Vitamin E is safer than the conventional drugs used for chorea in children. It was found effective in this case series. Its role needs further evaluation by a double-blind randomized controlled trial.


Subject(s)
Child , Chorea/drug therapy , Drug Administration Schedule , Female , Humans , Prognosis , Rheumatic Fever/complications , Treatment Outcome , Vitamin E/administration & dosage
11.
Indian Pediatr ; 1990 Jun; 27(6): 585-9
Article in English | IMSEAR | ID: sea-7600

ABSTRACT

Antigen A 60 of Mycobacterium bovis is a cell wall antigen with almost complete cross reactivity with antigen A 60 of Mycobacterium tuberculosis. This antigen was used for the ELISA technique for 100 cases suspected of childhood tuberculosis to evaluate the usefulness of the method in the diagnosis. The positivity rate in pulmonary tuberculosis was 65.1%, in central nervous system tuberculosis 50.0% and in the miscellaneous group 76.4%. The overall positivity was 61.0%, proving the utility of the method for diagnosis.


Subject(s)
Adolescent , Antigens, Bacterial/diagnosis , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Female , Humans , Infant , Male , Mycobacterium bovis/immunology , Sensitivity and Specificity , Tuberculosis/diagnosis , Tuberculosis, Pulmonary/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL